Updated:
Medtronic Retirement Plan for Certain Participants and Beneficiaries
The Medtronic Retirement Plan for Certain Participants and Beneficiaries was established effective May 1, 2019, as part of Medtronic plc's restructuring of its...
Medtronic Retirement Plan for Certain Participants and Beneficiaries
The Medtronic Retirement Plan for Certain Participants and Beneficiaries was established effective May 1, 2019, as part of Medtronic plc's restructuring of its U.S. retirement benefits. The plan consolidated and replaced portions of legacy pension obligations, creating a bifurcated structure: participants accrue benefits under either a Final Average Pay formula or a Personal Pension Account, depending on their hire date and eligibility. The plan is sponsored and administered by Medtronic plc, the Dublin-domiciled, Minneapolis-operated medical technology corporation with a market capitalization exceeding $110 billion (public record). CEO Geoff Martha represents the plan sponsor in strategic governance matters. The plan's investment portfolio functions as a corporate defined-benefit vehicle with allocations spanning public equities, fixed income, real estate, and private markets. Medtronic's treasury and corporate finance team, led by Vice President Christopher Lewis, manages pension assets alongside the firm's broader capital-preservation vehicles, including the Medtronic Capital Preservation Fund. While the plan does not publicly disclose asset allocation weights, Medtronic's status as a Fortune 500 multinational operating in more than 150 countries suggests a globally diversified, liability-driven investment posture typical of large corporate pensions. The plan's obligations include legacy final-average-pay participants — long-tenured employees whose benefit formulas predate Medtronic's 2015 acquisition of Covidien — as well as newer employees earning portable account balances. As a pension fund embedded within an operating company, the plan lacks a standalone investment team or external office footprint. Investment decisions are made by Medtronic's corporate finance function, which also oversees the company's real estate portfolio and insurance captives. Geoff Martha, named CEO in April 2020, is a member of the Business Roundtable and the World Economic Forum International Business Council, connecting the plan sponsor to peer corporate treasuries and institutional allocators. The plan also interfaces with Medtronic's joint venture structures: certain plan assets were transferred to Mozarc Medical, a kidney-care joint venture with DaVita Inc., reflecting how operating-company strategy can reshape pension liabilities. The plan's structural differentiator is its hybrid benefit design — neither a pure defined-benefit plan nor a 401(k) — which places its liability profile between frozen legacy pools and modern participant-directed accounts. This structure demands an investment strategy that balances long-duration fixed income for final-average-pay accruals with growth-seeking allocations that support portable account balances. For an institutional allocator evaluating the plan as a co-investor or LP, the relevant counterparty is not a standalone CIO but Medtronic's corporate treasury, where pension management is intertwined with the parent's balance-sheet priorities and global tax strategy.
General information
Firm type
Pension Fund
Year founded
2019
Location
Region
North America
Country
United States
City
Minneapolis
Corporate office
Minneapolis, MN, United States
Principals
Geoff Martha
Chairman and CEO, Medtronic plc
Christopher Lewis
Vice President of Corporate Finance, Pension and Real Estate, Medtronic plc
Michelle Quinn
Secretary of the Board of Directors, Medtronic plc
Sector focus
Frequently asked questions
Who runs investment decisions for the Medtronic Retirement Plan?
Investment decisions are made by Medtronic's corporate finance and treasury function, overseen by Vice President of Corporate Finance Christopher Lewis, who manages both pension and real estate portfolios. Unlike a standalone public pension fund, there is no independent investment committee or CIO. The plan's investment strategy is ultimately governed by Medtronic's board of directors and its fiduciary duty as plan sponsor under ERISA.
How does the plan's hybrid benefit structure affect its liability profile?
The plan pays two distinct benefit types: Final Average Pay Pension Benefits for legacy participants and Personal Pension Account Benefits for newer hires. This bifurcation means the plan carries long-duration liabilities for final-average-pay accruals, which require interest-rate-sensitive fixed-income allocations, alongside shorter-duration, growth-oriented obligations for portable account balances. The mix makes the plan's liability-driven investing strategy more complex than a frozen legacy pension or a standard 401(k).
What is the plan's relationship to Medtronic's joint venture with DaVita?
Certain plan assets or liabilities were transferred in connection with the formation of Mozarc Medical, a kidney-care joint venture between Medtronic and DaVita Inc. This transfer reflects Medtronic's corporate practice of restructuring pension obligations alongside operational carve-outs, making the plan's asset base and participant pool responsive to the parent company's M&A and divestiture activity.
Does the plan have a publicly disclosed asset allocation or AUM?
No. Medtronic does not publish a separate AUM figure or detailed asset allocation for this specific plan. Filings with the U.S. Department of Labor provide some visibility into the plan's holdings and funded status, but the plan does not maintain a standalone investor-relations function. Allocators seeking co-investment opportunities must engage through Medtronic's corporate treasury.
How does Medtronic's global footprint influence the plan's investment strategy?
Medtronic operates in more than 150 countries and reports revenue in a mix of developed-market and emerging-market currencies, which introduces currency-hedging considerations into the pension portfolio. While the plan's liabilities are predominantly USD-denominated, the sponsor's global cash flows may influence the treasury team's decisions around international equity, infrastructure, and real asset exposures within the pension trust.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on pension funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: